Table 3.
Staphylococcus aureus clinical isolates obtained from patient urinary catheters or breast implants with varying antibiotic resistance/recalcitrance profiles. MRSA-Methicillin Resistant S. aureus. MSSA-Methicillin sensitive S. aureus. Gent-Gentamicin. Cef-Cefazolin. Bac-Bacitracin. Cipro-Ciprofloxacin. Nitro-Nitrofurantoin. BISA-breast implant S. aureus. HUC-human urinary catheter. S-susceptible. R-resistant. N/A-not applicable.
| Strains | Isolation site | Details | Antimicrobial Susceptibilities |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Gent | Cef | Bac | Cipro | Nitro | MethicillinR/mecA | Reference | |||
| JE2 | Skin | Well-characterized | S | S | R | R | S | MRSA/YES | This study and [24] |
| BISA 117 | Breast Implant | Clinical | S | S | R | N/A | N/A | MSSA/NO | 23 |
| BISA 158 | Breast Implant | Clinical | S | S | R | N/A | N/A | MSSA/NO | 23 |
| HUC 86–07c | Urinary Catheter | Clinical | S | S | N/A | S | S | MSSA/NO | This study and [25] |
| HUC 95 | Urinary Catheter | Clinical | S | S | N/A | S | S | MSSA/NO | This study and [25] |
| HUC 97–02 | Urinary Catheter | Clinical | S | S | N/A | R | S | MSSA/NO | This study and [25] |
| HUC 111–01c | Urinary Catheter | Clinical | S | S | N/A | S | S | MSSA/NO | This study and [25] |